Ignite Creation Date:
2024-05-05 @ 10:47 PM
Last Modification Date:
2024-10-26 @ 10:24 AM
Study NCT ID:
NCT01189383
Status:
COMPLETED
Last Update Posted:
2016-12-22
First Post:
2010-08-25
Brief Title:
IL15 Dendritic Cell Vaccine for Patients With Resected Stage III A B or C or Stage IV Melanoma
Sponsor:
Baylor Research Institute
Organization:
Baylor Research Institute
Organization Data
Organization:
Baylor Research Institute
Class:
OTHER
Study ID:
009-273
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Baylor Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |
| National Institutes of Health NIH | NIH |